JP2017533215A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533215A5
JP2017533215A5 JP2017523293A JP2017523293A JP2017533215A5 JP 2017533215 A5 JP2017533215 A5 JP 2017533215A5 JP 2017523293 A JP2017523293 A JP 2017523293A JP 2017523293 A JP2017523293 A JP 2017523293A JP 2017533215 A5 JP2017533215 A5 JP 2017533215A5
Authority
JP
Japan
Prior art keywords
methyl
pyrido
pyrimidin
amino
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523293A
Other languages
English (en)
Japanese (ja)
Other versions
JP6505222B2 (ja
JP2017533215A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2015/011386 external-priority patent/WO2016068580A2/en
Publication of JP2017533215A publication Critical patent/JP2017533215A/ja
Publication of JP2017533215A5 publication Critical patent/JP2017533215A5/ja
Application granted granted Critical
Publication of JP6505222B2 publication Critical patent/JP6505222B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523293A 2014-10-29 2015-10-27 ヒストンリジン脱メチル化触媒活性を調節するための新規ピリドピリミジノン化合物 Expired - Fee Related JP6505222B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462069915P 2014-10-29 2014-10-29
US62/069,915 2014-10-29
PCT/KR2015/011386 WO2016068580A2 (en) 2014-10-29 2015-10-27 Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)

Publications (3)

Publication Number Publication Date
JP2017533215A JP2017533215A (ja) 2017-11-09
JP2017533215A5 true JP2017533215A5 (https=) 2018-11-01
JP6505222B2 JP6505222B2 (ja) 2019-04-24

Family

ID=55851908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017523293A Expired - Fee Related JP6505222B2 (ja) 2014-10-29 2015-10-27 ヒストンリジン脱メチル化触媒活性を調節するための新規ピリドピリミジノン化合物

Country Status (13)

Country Link
US (1) US9834550B2 (https=)
EP (1) EP3212647B1 (https=)
JP (1) JP6505222B2 (https=)
KR (1) KR101978899B1 (https=)
CN (1) CN107001358A (https=)
AU (1) AU2015340215B2 (https=)
BR (1) BR112017008312A2 (https=)
CA (1) CA2962917C (https=)
MX (1) MX2017005346A (https=)
NZ (1) NZ730475A (https=)
RU (1) RU2684396C2 (https=)
SG (1) SG11201702075QA (https=)
WO (1) WO2016068580A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3359154B1 (en) * 2015-10-08 2021-05-26 Suzhou Yunxuan Yiyao Keji Youxian Gongsi Wnt signaling pathway inhibitors and therapeutic applications thereof
JP7114076B2 (ja) 2015-12-22 2022-08-08 シャイ・セラピューティクス・エルエルシー がん及び炎症性疾患の処置のための化合物
JP7514005B2 (ja) 2017-06-21 2024-07-10 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのrasスーパーファミリーと相互作用する化合物
CN112119065B (zh) * 2018-07-13 2024-01-23 四川科伦博泰生物医药股份有限公司 苯并二氮杂环类化合物、其制备方法及用途
JP7407461B2 (ja) 2018-12-19 2024-01-04 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物
US20230110603A1 (en) 2020-01-31 2023-04-13 Kumiai Chemical Industry Co., Ltd. 3-alkoxybenzamide derivative, and pest control agent
WO2021198191A1 (en) 2020-03-30 2021-10-07 Enyo Pharma Quinazolinone derivatives and uses thereof for treating a cancer
US20230150978A1 (en) * 2020-03-30 2023-05-18 Enyo Pharma Quinazolinone derivatives and uses thereof for treating a cancer
GB202114315D0 (en) * 2021-10-06 2021-11-17 Duke Street Bio Ltd Pharmaceutical compound
US20240217968A1 (en) * 2021-03-31 2024-07-04 Duke Street Bio Limited Pharmaceutical compound

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939421A (en) * 1997-07-01 1999-08-17 Signal Pharmaceuticals, Inc. Quinazoline analogs and related compounds and methods for treating inflammatory conditions
GB9909135D0 (en) * 1999-04-22 1999-06-16 Univ Wales Medicine Cystic fibrosis medicaments
MXPA04004955A (es) * 2001-11-26 2004-08-11 Dsm Ip Assets Bv Procedimiento para la recuperacion de caprolactama.
FR2846657B1 (fr) 2002-11-05 2004-12-24 Servier Lab Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7232824B2 (en) * 2003-09-30 2007-06-19 Scios, Inc. Quinazoline derivatives as medicaments
NZ546477A (en) * 2006-04-07 2009-04-30 Auckland Uniservices Ltd 4-Alkylamino-2-(heterocyclic)quinazolines and their use in cancer therapy
WO2013012915A1 (en) * 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
US9914730B2 (en) * 2012-09-28 2018-03-13 Cancer Research Technology Limited Azaquinazoline inhibitors of Atypical protein Kinase C
RS55764B1 (sr) 2012-10-02 2017-07-31 Gilead Sciences Inhibitori histonskih demetilaza
US20150272939A1 (en) 2012-10-02 2015-10-01 Yale University Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase
WO2014087165A1 (en) * 2012-12-06 2014-06-12 University Of Bath Tankyrase inhibitors
CA2901022C (en) 2013-02-27 2021-05-04 Epitherapeutics Aps Substituted pyridine compounds as inhibitors of histone demethylases
JP6320506B2 (ja) 2013-03-12 2018-05-09 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
WO2014139326A1 (en) 2013-03-13 2014-09-18 Genentech, Inc. Pyrazolo compounds and uses thereof
HRP20171609T1 (hr) 2013-03-15 2017-12-15 Quanticel Pharmaceuticals Inc Inhibitori histon demetilaze
MX2016002794A (es) 2013-09-05 2016-09-13 Genentech Inc Compuestos antiproliferativos.
CN103694255A (zh) * 2014-01-09 2014-04-02 华中师范大学 吡啶并噁嗪酮和吡啶并嘧啶酮类化合物及其制备方法与应用
TWI675836B (zh) * 2014-03-25 2019-11-01 美商伊格尼塔公司 非典型蛋白質激酶c之氮雜喹唑啉抑制劑

Similar Documents

Publication Publication Date Title
JP2017533215A5 (https=)
JP6349360B2 (ja) Cb2アゴニストとして有用なピリジン−2−アミド
DE60028740T2 (de) Phthalazinderivate zur behandlung von entzündlichen erkrankungen
KR101078505B1 (ko) 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제
JP5818901B2 (ja) 疼痛、精神病性障害、認知障害、またはアルツハイマー病の治療のためのアルファ‐7ニコチン性受容体修飾薬
RU2017113007A (ru) Новые соединения пиридопиримидинона для модулирования каталитической активности гистонлизиндеметилаз (KDMS)
TWI400232B (zh) 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
EP3651762B1 (en) Antagonists of the muscarinic acetylcholine receptor m4
JP2012529535A (ja) キナーゼモジュレーターとして有用なニコチンアミド化合物
JP2017522346A (ja) ブロモドメインに対して活性な化合物
US20110166132A1 (en) Gamma Secretase Modulators
KR20120049940A (ko) 키나제 억제제로서의 헤테로아릴 화합물
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
KR20040048920A (ko) 글리코겐 신타아제 키나제 3-베타 저해제(gsk저해제)로서의 헤테로아릴 아민
JP2014506878A (ja) Cdk9阻害剤としての置換ビ−ヘテロアリール化合物およびそれらの使用
CA2634676A1 (en) Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp
JP2015052005A (ja) タンパク質キナーゼ調節剤としてのピリジンおよびピラジン誘導体
JP2011522865A (ja) Ia心不全および癌の治療に有用なプロテインキナーゼd阻害剤としての2,4’−ビピリジニル化合物
JPWO2010058846A1 (ja) 4,6−ジアミノニコチンアミド化合物
KR20160079907A (ko) 염증 질환의 치료에 사용되기 위한 화합물, 의약 조성물 및 방법
JP2012529435A (ja) アルカノイルアミノベンズアミドアニリンhdacインヒビター化合物
US20120165306A1 (en) Pyrazinylpyridines useful for the treatment of proliferative diseases
JP2004531571A (ja) サイトカイン生産のインヒビターとしてのカルバメート及びオキサミド化合物
UA122065C2 (uk) 5-[(піперазин-1-іл)-3-оксопропіл]-імідазолідин-2,4-діонові похідні як інгібітори adamts для лікування остеоартриту
KR101830566B1 (ko) 테트라히드로이소퀴놀린-1-온 유도체 또는 그의 염